Industry News
AtCor signs $800K contract expansion
AtCor Medical (ASX:ACG) has expanded an existing contract to supply its SphygmoCor diagnostic to the tune of $800,000. [ + ]
AtCor swings to profit
AtCor Medical (ASX:ACG) has reported its second ever half-year profit for 1H13 thanks to revenue growth and cost-cutting. [ + ]
New imaging device is flexible, flat and transparent
An Austrian research team has developed an entirely new way of capturing images based on a flat, flexible, transparent and potentially disposable polymer sheet. [ + ]
Birth order linked to increased risk of diabetes, metabolic disorders
Long a source of sibling rivalry, birth order may raise the risk of first-born children developing diabetes or high blood pressure. [ + ]
Movers & shakers: Another Farrell to head ResMed
Mick Farrell, son of Dr Peter Farrell, will take over as CEO of ResMed while his father transitions to non-executive chairman. [ + ]
PolyActiva $9.2m cash injection
PolyActiva has raised $9.2m to further the development of its polymer drug delivery technology platform. [ + ]
Phosphagenics working on topical opioid patch
Phosphagenics (ASX:POH) will bring a new product to trials after preclinical research showed oxycodone delivered with its TPM tech can provide pain relief without entering the blood. [ + ]
Neurotrauma research to benefit from development grants
Twelve new research projects focusing on improving outcomes for Transport Accident Commission (TAC) and WorkSafe Victoria clients have been funded through the Institute for Safety, Compensation and Recovery Research (ISCRR) 2013 Development Grants Program. [ + ]
UWA becomes a global online classroom
The first free online courses in arts and science are about to be offered at The University of Western Australia in collaboration with US internet-study pioneer Stanford University. [ + ]
Industry applauds Labor policy to aid innovation
Labor announced yesterday its long-awaited policy on jobs and innovation, offering several reforms aimed at aiding innovative companies and biotechs. [ + ]
Gene patent upheld by Federal Court
The Federal Court has ruled in favour of Myriad Genetics and its patent of mutations in the BRCA1 gene, although some have expressed concern at the result. [ + ]
Trans-Tasman action to fast-track rheumatic fever vaccine
The University of Western Australia and the Telethon Institute for Child Health Research have welcomed a commitment by the Australian and New Zealand Prime Ministers to fast-track the development of a vaccine against rheumatic fever. [ + ]
New hope for early diagnosis and treatment of Parkinson’s
Flinders University researchers have discovered that a protein in the brain may play a role in the development of Parkinson’s disease, a common degenerative neurological disorder which affects the control of body movements. [ + ]
Academy awards excellence in science
The Australian Academy of Science today opened applications for its 2014 round of prestigious awards, including career and early career researcher awards, travelling fellowships, research bursaries and conference support. [ + ]
Movers & shakers: Alchemia appoints new CEO
Alchemia has appointed former Chief Financial Officer Charles Walker to the post of Chief Executive after Peter Smith stepped down following the failed Audeo Oncology demerger. [ + ]